Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma
Clinical trial NCT06318286 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06318286
- Sponsor
- Hyogo Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-13
- Primary completion
- 2026-06-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.